Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery

scientific article

Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12975-010-0036-2
P698PubMed publication ID24323556

P50authorBenedikt M. KesslerQ30504197
P2093author name stringJames Kennedy
Michalis Papadakis
Ashok Handa
Alastair Buchan
Ediri Sideso
Cynthia Wright
P2860cites workThrombolysis for acute ischaemic strokeQ24240067
The human plasma proteome: history, character, and diagnostic prospectsQ28218148
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltonsQ28293769
Mass spectrometry in systems biology: an overview.Q30370771
Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasmaQ30835879
A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samplesQ30981833
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityQ31136536
Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniquesQ33209072
Reproducibility in protein profiling by MALDI-TOF mass spectrometryQ33280555
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerQ33306300
Characterization of the quantitative relationship between signal-to-noise (S/N) ratio and sample amount on-target by MALDI-TOF MS: Determination of chondroitin sulfate subsequent to enzymatic digestionQ33409184
Mixed-model of ANOVA for measurement reproducibility in proteomics.Q33456348
Approaching clinical proteomics: current state and future fields of application in fluid proteomicsQ33467523
Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionQ33576664
The MALDI-TOF mass spectrometric view of the plasma proteome and peptidomeQ36462611
Quantitative aspects of the matrix-assisted laser desorption mass spectrometry of complex oligosaccharidesQ36766558
Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteinsQ36816300
Blood biomarkers in the diagnosis of ischemic stroke: a systematic reviewQ37227913
Blood markers for the prognosis of ischemic stroke: a systematic reviewQ37415033
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatmentQ37635613
Proteomics research to discover markers: what can we learn from Netflix?Q37664306
Introduction: Advances in protein analysis for the clinical laboratoryQ40395725
Rules of evidence for cancer molecular-marker discovery and validationQ79852778
P433issue4
P921main subjectbiomarkerQ864574
reproducibilityQ1425625
P304page(s)304-314
P577publication date2010-08-14
P1433published inTranslational stroke researchQ26842494
P1476titleAssessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery
P478volume1

Reverse relations

cites work (P2860)
Q37998544Blood biomarkers in stroke: research and clinical practice
Q35648087Blood biomarkers of ischemic stroke
Q38079618Ischemic stroke biomarkers in blood
Q35580496Opportunities and challenges in omics
Q36953709Stroke-related translational research.

Search more.